Patna’s All India Institute of Medical Sciences (AIIMS) on Wednesday began the phase 2/3 clinical trial of Covaxin on children in the age group of 2 to 18 years. Among the 15 who voluntarily turned up, three were the first to be administered the initial doses.
All the volunteers had gone through the required screening process, such as the RT-PCR, antibody test and general check-up, reported Hindustan Times. After giving the shots, the vaccine recipients were monitored for two hours.
“We are commencing the trials today in the reverse order of age from today. Children in the 12 to 18 years age group will be given the shots first. We will then proceed with the 6 to 12 years age category before inoculating children in the 2 to 6 years age bracket,” the report quoted Dr CM Singh, AIIMS Patna superintendent and the principal investigator of the trial.
“Besides physical examination of the child, we will conduct real-time polymerase chain reaction (RT PCR) to check them for Covid antibody and test them for any pre-existing diseases before administering the vaccine,” Dr Singh said.
Reportedly, so far, 108 children have registered for the trial of Covaxin, made by Bharat Biotech International Limited, Hyderabad. All of them will go through the screening process before receiving 0.5ml dose of intramolecular injection. The two doses of the vaccine will be administered at an interval of 28 days.